Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

Open access
Sosinsky, Alona, Ambrose, John, Cross, William, Turnbull, Clare, Henderson, Shirley, Jones, Louise, Hamblin, Angela, Arumugam, Prabhu, Chan, Georgia, Chubb, Daniel, Noyvert, Boris, Mitchell, Jonathan, Walker, Susan, Bowman, Katy, Pasko, Dorota, Buongermino Pereira, Marianna, Volkova, Nadezda, Rueda-Martin, Antonio, Perez-Gil, Daniel, Lopez, Javier, Pullinger, John, Siddiq, Afshan, Zainy, Tala, Choudhury, Tasnim, Yavorska, Olena, Fowler, Tom, Bentley, David, Kingsley, Clare, Hing, Sandra, Deans, Zandra, Rendon, Augusto, Hill, Sue, Caulfield, Mark, Murugaesu, Nirupa · 2024 · Nature Medicine

Abstract

The Cancer Programme of the 100,000 Genomes Project was an initiative to provide whole-genome sequencing (WGS) for patients with cancer, evaluating opportunities for precision cancer care within the UK National Healthcare System (NHS). Genomics England, alongside NHS England, analyzed WGS data from 13,880 solid tumors spanning 33 cancer types, integrating genomic data with real-world treatment and outcome data, within a secure Research Environment. Incidence of somatic mutations in genes recommended for standard-of-care testing varied across cancer types. For instance, in glioblastoma multiforme, small variants were present in 94% of cases and copy number aberrations in at least one gene in 58% of cases, while sarcoma demonstrated the highest occurrence of actionable structural variants (13%). Homologous recombination deficiency was identified in 40% of high-grade serous ovarian cancer cases with 30% linked to pathogenic germline variants, highlighting the value of combined somatic and germline analysis. The linkage of WGS and longitudinal life course clinical data allowed the assessment of treatment outcomes for patients stratified according to pangenomic markers. Our findings demonstrate the utility of linking genomic and real-world clinical data to enable survival analysis to identify cancer genes that affect prognosis and advance our understanding of how cancer genomics impacts patient outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-023-02682-0

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 179

Metadata

Authors
Sosinsky, A., Ambrose, J., Cross, W., Turnbull, C., Henderson, S., Jones, L., Hamblin, A., Arumugam, P., Chan, G., Chubb, D., Noyvert, B., Mitchell, J., Walker, S., Bowman, K., Pasko, D., Buongermino Pereira, M., Volkova, N., Rueda-Martin, A., Perez-Gil, D., Lopez, J., Pullinger, J., Siddiq, A., Zainy, T., Choudhury, T., Yavorska, O., Fowler, T., Bentley, D., Kingsley, C., Hing, S., Deans, Z., Rendon, A., Hill, S., Caulfield, M., & Murugaesu, N.
Venue
Nature Medicine
Published
2024-01
Volume
30
Issue
1
Pages
279-289
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4390718808
Cited by
179
References
13
FWCI
27.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. https://app.cochat.ai/papers/10.1038/s41591-023-02682-0
The paper
Sosinsky, A., Ambrose, J., Cross, W., Turnbull, C., Henderson, S., Jones, L., Hamblin, A., Arumugam, P., Chan, G., Chubb, D., Noyvert, B., Mitchell, J., Walker, S., Bowman, K., Pasko, D., Buongermino Pereira, M., Volkova, N., Rueda-Martin, A., Perez-Gil, D., . . . Murugaesu, N. (2024). Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nature Medicine. https://doi.org/10.1038/s41591-023-02682-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.